
Isaac Shomer
Examiner (ID: 6016, Phone: (571)270-7671 , Office: P/1612 )
| Most Active Art Unit | 1612 |
| Art Unit(s) | 1612 |
| Total Applications | 1339 |
| Issued Applications | 756 |
| Pending Applications | 161 |
| Abandoned Applications | 487 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19947145
[patent_doc_number] => 12318483
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2025-06-03
[patent_title] => Manufacturing of bupivacaine multivesicular liposomes
[patent_app_type] => utility
[patent_app_number] => 18/957404
[patent_app_country] => US
[patent_app_date] => 2024-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 15
[patent_no_of_words] => 24346
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 234
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18957404
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/957404 | Manufacturing of bupivacaine multivesicular liposomes | Nov 21, 2024 | Issued |
Array
(
[id] => 19815136
[patent_doc_number] => 20250073343
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-03-06
[patent_title] => PROTEIN-LOADED PLGA NANOSPHERES
[patent_app_type] => utility
[patent_app_number] => 18/952404
[patent_app_country] => US
[patent_app_date] => 2024-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16173
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18952404
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/952404 | PROTEIN-LOADED PLGA NANOSPHERES | Nov 18, 2024 | Pending |
Array
(
[id] => 19799024
[patent_doc_number] => 20250064949
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-27
[patent_title] => PROTEIN-LOADED PLGA NANOSPHERES
[patent_app_type] => utility
[patent_app_number] => 18/946447
[patent_app_country] => US
[patent_app_date] => 2024-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16179
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18946447
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/946447 | PROTEIN-LOADED PLGA NANOSPHERES | Nov 12, 2024 | Pending |
Array
(
[id] => 19799024
[patent_doc_number] => 20250064949
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-27
[patent_title] => PROTEIN-LOADED PLGA NANOSPHERES
[patent_app_type] => utility
[patent_app_number] => 18/946447
[patent_app_country] => US
[patent_app_date] => 2024-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16179
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18946447
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/946447 | PROTEIN-LOADED PLGA NANOSPHERES | Nov 12, 2024 | Pending |
Array
(
[id] => 20006015
[patent_doc_number] => 20250144237
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-05-08
[patent_title] => AGENTS, COMPOSITIONS AND METHODS FOR ENHANCED DELIVERY OF NUCLEIC ACIDS TO THE CELLS WITHIN THE RESPIRATORY SYSTEM
[patent_app_type] => utility
[patent_app_number] => 18/939439
[patent_app_country] => US
[patent_app_date] => 2024-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7283
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18939439
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/939439 | AGENTS, COMPOSITIONS AND METHODS FOR ENHANCED DELIVERY OF NUCLEIC ACIDS TO THE CELLS WITHIN THE RESPIRATORY SYSTEM | Nov 5, 2024 | Pending |
Array
(
[id] => 20006015
[patent_doc_number] => 20250144237
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-05-08
[patent_title] => AGENTS, COMPOSITIONS AND METHODS FOR ENHANCED DELIVERY OF NUCLEIC ACIDS TO THE CELLS WITHIN THE RESPIRATORY SYSTEM
[patent_app_type] => utility
[patent_app_number] => 18/939439
[patent_app_country] => US
[patent_app_date] => 2024-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7283
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18939439
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/939439 | AGENTS, COMPOSITIONS AND METHODS FOR ENHANCED DELIVERY OF NUCLEIC ACIDS TO THE CELLS WITHIN THE RESPIRATORY SYSTEM | Nov 5, 2024 | Pending |
Array
(
[id] => 20212472
[patent_doc_number] => 12409106
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-09-09
[patent_title] => Medical material
[patent_app_type] => utility
[patent_app_number] => 18/922818
[patent_app_country] => US
[patent_app_date] => 2024-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 10
[patent_no_of_words] => 12483
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18922818
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/922818 | Medical material | Oct 21, 2024 | Issued |
Array
(
[id] => 20212472
[patent_doc_number] => 12409106
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-09-09
[patent_title] => Medical material
[patent_app_type] => utility
[patent_app_number] => 18/922818
[patent_app_country] => US
[patent_app_date] => 2024-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 10
[patent_no_of_words] => 12483
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18922818
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/922818 | Medical material | Oct 21, 2024 | Issued |
Array
(
[id] => 19768300
[patent_doc_number] => 20250049726
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-13
[patent_title] => MANGANESE-DOPED HOLLOW MESOPOROUS SILICA NANOPARTICLES LOADED WITH CURCUMIN
[patent_app_type] => utility
[patent_app_number] => 18/762795
[patent_app_country] => US
[patent_app_date] => 2024-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5223
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18762795
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/762795 | Manganese-doped hollow mesoporous silica nanoparticles loaded with curcumin | Jul 2, 2024 | Issued |
Array
(
[id] => 19608081
[patent_doc_number] => 12156940
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2024-12-03
[patent_title] => Manufacturing of bupivacaine multivesicular liposomes
[patent_app_type] => utility
[patent_app_number] => 18/761863
[patent_app_country] => US
[patent_app_date] => 2024-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 15
[patent_no_of_words] => 28444
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 213
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18761863
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/761863 | Manufacturing of bupivacaine multivesicular liposomes | Jul 1, 2024 | Issued |
Array
(
[id] => 19541670
[patent_doc_number] => 20240358706
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-31
[patent_title] => Methods for Treating Metastatic Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan and Oxaliplatin
[patent_app_type] => utility
[patent_app_number] => 18/676591
[patent_app_country] => US
[patent_app_date] => 2024-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20518
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18676591
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/676591 | Methods for Treating Metastatic Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan and Oxaliplatin | May 28, 2024 | Abandoned |
Array
(
[id] => 19526774
[patent_doc_number] => 20240350676
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-24
[patent_title] => COMPOSITIONS AND SYSTEMS COMPRISING TRANSFECTION-COMPETENT VESICLES FREE OF ORGANIC-SOLVENTS AND DETERGENTS AND METHODS RELATED THERETO
[patent_app_type] => utility
[patent_app_number] => 18/660467
[patent_app_country] => US
[patent_app_date] => 2024-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10746
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18660467
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/660467 | COMPOSITIONS AND SYSTEMS COMPRISING TRANSFECTION-COMPETENT VESICLES FREE OF ORGANIC-SOLVENTS AND DETERGENTS AND METHODS RELATED THERETO | May 9, 2024 | Pending |
Array
(
[id] => 19402058
[patent_doc_number] => 20240285569
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-29
[patent_title] => METHODS FOR DECREASING INJURIES ASSOCIATED WITH INTRAOPERATIVE HYPOTENSION
[patent_app_type] => utility
[patent_app_number] => 18/651154
[patent_app_country] => US
[patent_app_date] => 2024-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13012
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18651154
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/651154 | METHODS FOR DECREASING INJURIES ASSOCIATED WITH INTRAOPERATIVE HYPOTENSION | Apr 29, 2024 | Pending |
Array
(
[id] => 19762197
[patent_doc_number] => 12220468
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2025-02-11
[patent_title] => Atomic scale topical composition with enhanced interstitial cellular uptake for increased moisturizing, fluidity, antioxidant and radiation protection, antimicrobial cleansing and therapeutics for optimal dermal integrity and homeostasis
[patent_app_type] => utility
[patent_app_number] => 18/636721
[patent_app_country] => US
[patent_app_date] => 2024-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6985
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18636721
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/636721 | Atomic scale topical composition with enhanced interstitial cellular uptake for increased moisturizing, fluidity, antioxidant and radiation protection, antimicrobial cleansing and therapeutics for optimal dermal integrity and homeostasis | Apr 15, 2024 | Issued |
Array
(
[id] => 19297525
[patent_doc_number] => 20240226090
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-11
[patent_title] => Methods For Treating Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan
[patent_app_type] => utility
[patent_app_number] => 18/613609
[patent_app_country] => US
[patent_app_date] => 2024-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17056
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18613609
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/613609 | Methods For Treating Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan | Mar 21, 2024 | Abandoned |
Array
(
[id] => 19570229
[patent_doc_number] => 20240374521
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-14
[patent_title] => RIBOSE CATIONIC LIPIDS
[patent_app_type] => utility
[patent_app_number] => 18/609160
[patent_app_country] => US
[patent_app_date] => 2024-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45397
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18609160
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/609160 | RIBOSE CATIONIC LIPIDS | Mar 18, 2024 | Pending |
Array
(
[id] => 20385453
[patent_doc_number] => 12485163
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-02
[patent_title] => Cancer therapy compositions and uses thereof
[patent_app_type] => utility
[patent_app_number] => 18/607029
[patent_app_country] => US
[patent_app_date] => 2024-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 35
[patent_no_of_words] => 43373
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18607029
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/607029 | Cancer therapy compositions and uses thereof | Mar 14, 2024 | Issued |
Array
(
[id] => 19447464
[patent_doc_number] => 20240307594
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-19
[patent_title] => MEDICAL DEVICES INCLUDING THERAPEUTIC COATINGS FORMED FROM INDIVIDUALLY ENCAPSULATED THERAPEUTIC AGENT CRYSTALS
[patent_app_type] => utility
[patent_app_number] => 18/606526
[patent_app_country] => US
[patent_app_date] => 2024-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9012
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18606526
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/606526 | MEDICAL DEVICES INCLUDING THERAPEUTIC COATINGS FORMED FROM INDIVIDUALLY ENCAPSULATED THERAPEUTIC AGENT CRYSTALS | Mar 14, 2024 | Pending |
Array
(
[id] => 19447464
[patent_doc_number] => 20240307594
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-19
[patent_title] => MEDICAL DEVICES INCLUDING THERAPEUTIC COATINGS FORMED FROM INDIVIDUALLY ENCAPSULATED THERAPEUTIC AGENT CRYSTALS
[patent_app_type] => utility
[patent_app_number] => 18/606526
[patent_app_country] => US
[patent_app_date] => 2024-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9012
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18606526
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/606526 | MEDICAL DEVICES INCLUDING THERAPEUTIC COATINGS FORMED FROM INDIVIDUALLY ENCAPSULATED THERAPEUTIC AGENT CRYSTALS | Mar 14, 2024 | Pending |
Array
(
[id] => 20385453
[patent_doc_number] => 12485163
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-02
[patent_title] => Cancer therapy compositions and uses thereof
[patent_app_type] => utility
[patent_app_number] => 18/607029
[patent_app_country] => US
[patent_app_date] => 2024-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 35
[patent_no_of_words] => 43373
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18607029
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/607029 | Cancer therapy compositions and uses thereof | Mar 14, 2024 | Issued |